Can we detect psychotic-like experiences in the general population?

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 376-385

  Nelson, B ^a   Fusar Poli, P ^a   Yung, A R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Psychosis; Risk; Schizophrenia

Indexed keywords

COGNITION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; PARANOIA; PERCEPTION DISORDER; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; PSYCHOTIC LIKE EXPERIENCE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; THOUGHT DISORDER;

HUMANS; POPULATION SURVEILLANCE; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 84856521433     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316136     Document Type: Review

References (99)

1. Meehl PE. Schizotaxia, schizotypy, schizophrenia. American Psychologist 1962; 17: 827-38.
2. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophrenia Research 2003; 60: 21-32.
3. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Psychology 1994; 103: 171-83.
4. Claridge G. Schizotypy: Implications for illness and health. New York, NY, US: Oxford University Press. (1997). xii, 340 pp. 1997.
5. van Os J, Hanssen M, Bijl RV, Ravelli A. Straus (1969) revisited: A psychosis continuum in the general population? Schizophrenia Research 2000; 45: 11-20.
6. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistenceimpairment model of psychotic disorder. Psychol Med 2009; 39: 179-95.
7. Kretschmer E. Physique and character: an investigation of the nature of constitution and of the theory of temperament. Harcourt Brace: New York 1925.
8. Strauss JS. Hallucinations and delusions as points on continua function. Archives of General Psychiatry 1969; 21: 581-6.
9. Eaton WW, Romanoski A, Anthony JC, Nestadt G. Screening for psychosis in the general population with a self-report interview. Journal of Nervous & Mental Disease 1991; 179: 689-93.
10. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: the National Comorbidity Survey. Archives of General Psychiatry 1996; 53: 1022-31.
11. Tien AY. Distributions of hallucinations in the population. Social Psychiatry & Psychiatric Epidemiology 1991; 26: 287-292.
12. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of General Psychiatry 2001; 58: 663-8.
13. Dhossche D, Ferdinand R, Van der Ende J, Hofstra MB, Verhulst F. Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychological Medicine 2002; 32: 619-27.
14. Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, Bebbington P, Jenkins R, Meltzer H. Prevalence and correlates of self-reported psychotic symptoms in the British population. The British journal of psychiatry: the journal of mental science 2004; 185: 298-305.
15. Fonseca-Pedrero E, Lemos-Giraldez S, Muniz J, Garcia-Cueto E, Campillo-Alvarez A. Schizotypy in adolescence: the role of gender and age. J Nerv Ment Dis 2008; 196: 161-5.
16. Scott J, Martin G, Bor W, Sawyer M, Clark J, McGrath J. The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res 2009; 107: 179-85.
17. Meehl PE. Schizotaxia revisited. Archives of General Psychiatry 1989; 46: 935-44.
18. Chapman LJ, Edell WS, Chapman JP. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull 1980; 6: 639-53.
19. Chapman JP, Chapman LJ. Psychosis proneness. In: Alpert M, ed., Controversies in schizophrenia: Changes and constancies. Guilford: New York 1985; pp. 157-74.
20. Chapman LJ, Chapman JP. The search for symptoms predictive of schizophrenia. Schizophrenia Bulletin 1987; 13: 497-503.
21. Cougnard A, Marcelis M, Myin-Germeys I, et al. Does normal developmental expression of psychosis combine with environmental risk to cuase persistence of psychosis? A psychosis proneness-persistence model. Psychol Med 2007; 37: 513-27.
22. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 2005; 44: 181-191.
23. Shevlin M, Murphy J, Dorahy MJ, Adamson G. The distribution of positive psychosis-like symptoms in the population: A latent class analysis of the National Comorbidity Survey. Schizophr Res 2007; 89: 101-9.
24. Spauwen J, Krabbendam L, Lieb R, Wittchen H-U, van Os J. Impact of psychological trauma on the development of psychotic symptoms: Relationship with psychosis proneness. British Journal of Psychiatry Vol 188 Jun 2006, 527-533.
25. Verdoux H, van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res 2002; 54: 59-65.
26. Vollema MG, Sitskoorn MM, Appels MC, Kahn RS. Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res 2002; 54: 39-45.
27. Allardyce J, Suppes T, Van Os J. Dimensions and the psychosis phenotype. International Journal of Methods in Psychiatric Research 2007; 16 (S1): 34-40.
28. Rossler W, Riecher-Rossler A, Angst J, et al. Psychotic experiences in the general population: A twenty year prospective community study. Schizophr Res 2007; 92: 1-14.
29. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of general psychiatry 2000; 57: 1053-1058.
30. Zubin J, Spring B. Vulnerability - a new view of schizophrenia. J Abnormal Psychology 1977; 86: 103-126.
31. Claridge G. The schizophrenias as nervous types. Br J Psychiatry 1972; 121: 1-17.
32. Claridge G. Single indicator of risk for schizophrenia: Probable fact or likely myth? Schizophrenia Bulletin 1994; 20: 151-168.
33. Claridge G, McCreery C, Mason O, et al. The factor structure of schizotypal' traits: a large replication study. British Journal of Clinical Psychology 1996; 35: 103-115.
34. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S. The Near Babylonian Speech Confusion in Early Detection of Psychosis. Schizophr Bull.
35. Kelleher I, Harley M, Murtagh A, Cannon M. Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull; 37: 362-369.
36. Liraud F, Droulout T, Parrot M, Verdoux H. Agreement between self-rated and clinically assessed symptoms in subjects with psychosis. The Journal of Nervous and Mental Disease 2004; 192: 352-356.
37. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. III. Schizophreniarelated personality disorders in relatives. Archives of General Psychiatry 1993; 50: 781-788.
38. Vollema MG, Sitskoorn MM, Appels MC, Kahn RS. Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophrenia Research 2002; 54: 39-45.
39. Fanous A, Gardner C, Walsh D, Kendler KS. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Archives of General Psychiatry Vol 58(7) Jul 2001, 669-673 2001.
40. Hanssen M, Krabbendam L, Vollema M, Delespaul P, Van Os J. Evidence for Instrument and Family-Specific Variation of Subclinical Psychosis Dimensions in the General Population. Journal of Abnormal Psychology Vol 115(1) Feb 2006, 5-14 2006.
41. Polanczyk G, Moffitt TE, Arseneault L, et al. Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Archives of general psychiatry 2010; 67: 328-38.
42. Spauwen J, Krabbendam L, Lieb R, Wittchen H-U, Van Os J. Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychological Medicine 2006; Vol 36(3) 407-415 2006.
43. Spauwen J, Krabberidam L, Lieb R, Wittchen H-U, van Os J. Does urbanicity shift the population expression of psychosis? Journal of Psychiatric Research Vol 38(6) Nov-Dec 2004, 613-8 2004.
44. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: The correlates of CIDI psychosis screen items in an Australian sample. Psychological Medicine Vol 36(2) Feb 2006, 231-238 2006.
45. Johns LC, Nazroo JY, Bebbington P, Kuipers E. Occurrence of hallucinatory experiences in a community sample and ethnic variations. British Journal of Psychiatry 2002; 180.
46. Laurens KR, West SA, Murray RM, Hodgins S. Psychotic-like experiences and other antecedents of schizophrenia in children aged 9-12 years: a comparison of ethnic and migrant groups in the United Kingdom. Psychological medicine 2008; 38: 1103-11.
47. Lataster T, van Os J, Drukker M, et al. Childhood victimisation and developmental expression of non-clinical delusional ideation and hallucinatory experiences: victimisation and non-clinical psychotic experiences. Social psychiatry and psychiatric epidemiology 2006; 41: 423-8.
48. Kelleher I, Harley M, Lynch F, Arseneault L, Fitzpatrick C, Cannon M. Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br J Psychiatry 2008; 193: 378-82.
49. Campbell ML, Morrison AP. The relationship between bullying, psychotic-like experiences and appraisals in 14-16-year olds. Behaviour research and therapy 2007; 45: 1579-91.
50. Nishida A, Tanii H, Nishimura Y, et al. Associations between psychotic-like experiences and mental health status and other psychopathologies among Japanese early teens. Schizophrenia research 2008; 99: 125-33.
51. Schreier A, Wolke D, Thomas K, et al. Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Archives of general psychiatry 2009; 66: 527-36.
52. Miettunen J, Tormanen S, Murray GK, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence. The British journal of psychiatry 2008; 192: 470-1.
53. Harley M, Kelleher I, Clarke M, et al. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychological medicine 2010; 40: 1627-134.
54. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. The British journal of psychiatry: the journal of mental science 2006; 188: 519-526.
55. Zammit S, Odd D, Horwood J, et al. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychological medicine 2009; 39: 1457-1467.
56. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R. Evidence for early-childhood pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Archives of General Psychiatry 2002; 59: 449-457.
57. Jacobson S, Kelleher I, Harley M, et al. Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. NeuroImage 2010; 49: 1875-1885.
58. Horwood J, Salvi G, Thomas K, et al. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. The British journal of psychiatry: the J mental science 2008; 193: 185-91.
59. Krabbendam L, Myin-Germeys I, Hanssen M, van Os J. Familial covariation of the subclinical psychosis phenotype and verbal fluency in the general population. Schizophrenia Research 2005; 74: 37-41.
60. Blanchard MM, Jacobson S, Clarke MC, et al. Language, motor and speed of processing deficits in adolescents with subclinical psychotic symptoms. Schizophrenia research 2010; 123: 71-76.
61. Dhossche D, Ferdinand R, Van der Ende J, Hofstra MB, Verhulst F. Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychol Med 2002; 32: 619-627.
62. Yung AR, Buckby JA, Cotton SM, et al. Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull 2006; 32: 352-359.
63. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry 2006; 188: 519-526.
64. Krabbendam L, van Os J. Schizophrenia and Urbanicity: A Major Environmental Influence - Conditional on Genetic Risk. Schizophrenia Bulletin 2005; 31: 795-9.
65. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 2004; 67: 131-42.
66. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry 2001; 58: 158-64.
67. Gross G, Huber G, Klosterkotter J. Bonn scale for the assessment of basic symptoms - BSABS. Springer: Berlin 1987.
68. Welham J, Scott J, Williams G, et al. Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study. Psychol Med 2009; 39: 625-34.
69. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull; 37: 84-93.
70. Hanssen M, Bak M, Bijl RV, Vollebergh W, and, Os Jv. Outcome of Self-reported Psychotic Experiences in the General Population: a Prospective Study. In: ed.^eds. 2002; pp. 15.
71. van Os J, Kapur S. Schizophrenia. Lancet 2009; 374: 635-45.
72. Armando M, Nelson B, Yung AR, et al. Psychotic-like experiences and correlation with distress and depressive symptoms in a community sample of adolescents and young adults. Schizophrenia research 2010; 119: 258-265.
73. Mackie CJ, Castellanos-Ryan N, Conrod PJ. Developmental trajectories of psychotic-like experiences across adolescence: impact of victimization and substance use. Psychological medicine 2011; 41: 47-58.
74. Yung AR, Buckby JA, Cosgrave EM, et al. Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophrenia Research 2007; 91: 246-53.
75. Verdoux H, Van Os J, Maurice-Tison S, Gay B, Salamon R, Bourgeois ML. Increased occurrence of depression in psychosisprone subjects: A follow-up study in primary care settings. Comprehensive Psychiatry 1999; 40: 462-468.
76. Wigman JT, Lin A, Vollebergh WA, et al. Subclinical psychosis and depression: Co-occurring phenomena that do not predict each other over time. Schizophrenia research 2011.
77. Krabbendam L, Myin-Germeys I, Hanssen M, de Graaf R, Vollebergh W, Bak M, van Os J. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology 2005; 44: 113-25.
78. Häfner H, Löffler, W., Maurer, K., et al. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica 1999; 100: 105-118.
79. Yung AR, McGorry PD. The initial prodrome in psychosis: Descriptive and qualitative aspects. Australian and New Zealand Journal of Psychiatry 1996; 30: 587-599.
80. Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P. Social dysfunction preducts two years clinical outcomes in people at ultrahigh risk for psychosis. Journal of Psychiatric Research 2009; 44: 294-301.
81. Fusar-Poli P, Bonoldi I, Yung AR, et al. Unpublished data. submitted 2011.
82. Thompson A, Nelson B, Yung AR. Predictive validity of clinical variables in the at risk for psychosis population: international comparisons with results from the North American Prodrome Longitudinal Study. Schizophr Res 2010: Oct 28 Epub.
83. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen H-U, Van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ: British Medical Journal Vol 330(7481) Jan 2005, 1-5 2005.
84. Lin A, Wigman JT, Nelson B, et al. The relationship between coping and subclinical psychotic experiences in adolescents from the general population - a longitudinal study. Psychological medicine 2011: 1-12.
85. Collip D, Myin-Germeys I, Van Os J. Does the concept of sensitization provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 2008; 34: 220-5.
86. Kelleher I, Jenner JA, Cannon M. Psychotic symptoms in the general population - an evolutionary perspective. The British Journal of Psychiatry; 197: 167-169.
87. Nettle D. Strong imagination: Madness, creativity and human nature. Oxford University Press: Oxford 2001.
88. Nettle D. Schizotypy and mental health amongst poets, visual artists, and mathematicians. Journal of Research in Personality 2006; 40: 876-890.
89. Nettle D, Clegg H. Schizotypy, creativity and mating success in humans. Proc Biol Sci 2006; 273: 611-615.
90. Schuldberg D. Six subclinical spectrum traits in normal creativity. Creativity Research Journal, 2000-2001; 13: 5-16.
91. Ingason A, Rujescu D, Cichon S, et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Molecular psychiatry 2011; 16: 17-25.
92. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. State and trait predictors of transition to first episode psychosis among individuals with at risk mental states. Schizophrenia Research 2004; 71: 227-237.
93. Haroun N, Dunn L, Haroun A, Cadenhead K. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32: 166-178.
94. Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, Verdoux H, Van Os J. Evidence that three dimensions of psychosis have a distribution in the general population. Psychological medicine 2002; 32: 347-358.
95. Yung AR, Nelson B, Baker K, Buckby JA, Baksheev G, Cosgrave EM. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry 2009; 43: 118-128.
96. Wigman JT, Vollebergh WA, Raaijmakers QA, Iedema J, van Dorsselaer S, Ormel J, Verhulst FC, van Os J. The Structure of The Extended Psychosis Phenotype in Early Adolescence--A Crosssample Replication. Schizophrenia bulletin 2009.
97. Verdoux H, van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia research 2002; 54: 59-65.
98. Nelson B, Yung AR. Psychotic-like experiences as overdetermined phenomena: When do they increase risk for psychotic disorder? Schizophr Res 2009; 108: 303-4.
99. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996; 22: 283-303.